Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Candida albicans biofilm-defective mutants.

Richard ML, Nobile CJ, Bruno VM, Mitchell AP.

Eukaryot Cell. 2005 Aug;4(8):1493-502.

2.

Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms.

Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP.

Arch Oral Biol. 2009 Nov;54(11):1052-60. doi: 10.1016/j.archoralbio.2009.08.002. Epub 2009 Aug 26.

PMID:
19712926
3.

Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, and biofilm formation.

Hiller E, Heine S, Brunner H, Rupp S.

Eukaryot Cell. 2007 Nov;6(11):2056-65. Epub 2007 Sep 28.

4.

Purpurin suppresses Candida albicans biofilm formation and hyphal development.

Tsang PW, Bandara HM, Fong WP.

PLoS One. 2012;7(11):e50866. doi: 10.1371/journal.pone.0050866. Epub 2012 Nov 30.

5.

The Flo8 transcription factor is essential for hyphal development and virulence in Candida albicans.

Cao F, Lane S, Raniga PP, Lu Y, Zhou Z, Ramon K, Chen J, Liu H.

Mol Biol Cell. 2006 Jan;17(1):295-307. Epub 2005 Nov 2.

6.

In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions.

Thein ZM, Samaranayake YH, Samaranayake LP.

Arch Oral Biol. 2007 Aug;52(8):761-7. Epub 2007 Feb 23.

PMID:
17321487
7.

Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device.

Parahitiyawa NB, Samaranayake YH, Samaranayake LP, Ye J, Tsang PW, Cheung BP, Yau JY, Yeung SK.

APMIS. 2006 Apr;114(4):298-306.

PMID:
16689830
8.

Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces.

Swindell K, Lattif AA, Chandra J, Mukherjee PK, Ghannoum MA.

J Infect Dis. 2009 Aug 1;200(3):473-80. doi: 10.1086/600106.

PMID:
19552524
9.
10.

Tetracycline effects on Candida albicans virulence factors.

McCool L, Mai H, Essmann M, Larsen B.

Infect Dis Obstet Gynecol. 2008;2008:493508. doi: 10.1155/2008/493508.

11.
12.

Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.

Bruzual I, Riggle P, Hadley S, Kumamoto CA.

J Antimicrob Chemother. 2007 Mar;59(3):441-50. Epub 2007 Jan 29.

PMID:
17261564
13.

Bioactivity and architecture of Candida albicans biofilms developed on poly(methyl methacrylate) resin surface.

da Silva WJ, Seneviratne J, Samaranayake LP, Del Bel Cury AA.

J Biomed Mater Res B Appl Biomater. 2010 Jul;94(1):149-56. doi: 10.1002/jbm.b.31635.

PMID:
20524189
14.

Effects of extracellular DNA from Candida albicans and pneumonia-related pathogens on Candida biofilm formation and hyphal transformation.

Sapaar B, Nur A, Hirota K, Yumoto H, Murakami K, Amoh T, Matsuo T, Ichikawa T, Miyake Y.

J Appl Microbiol. 2014 Jun;116(6):1531-42. doi: 10.1111/jam.12483. Epub 2014 Mar 24.

15.

Prostaglandin production during growth of Candida albicans biofilms.

Alem MA, Douglas LJ.

J Med Microbiol. 2005 Nov;54(Pt 11):1001-5.

PMID:
16192429
16.

Role of CaBud6p in the polarized growth of Candida albicans.

Song Y, Kim JY.

J Microbiol. 2006 Jun;44(3):311-9.

18.

Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain.

Pérez A, Pedrós B, Murgui A, Casanova M, López-Ribot JL, Martínez JP.

FEMS Yeast Res. 2006 Nov;6(7):1074-84.

19.

Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation.

Harriott MM, Noverr MC.

Antimicrob Agents Chemother. 2010 Sep;54(9):3746-55. doi: 10.1128/AAC.00573-10. Epub 2010 Jun 21.

Supplemental Content

Support Center